Aim #4: To determine if PROMIS (patient reported outcome measurement information system) is a useful instrument for assessing outcomes in women with fibromyalgia by comparing the PROMIS modules to symptom domains measured by other instruments validated for use in fibromyalgia clinical trials and by determining the performance of PROMIS in the definition of responders.